
The Challenge
Clinical development leaders at a global pharmaceutical company faced mounting pressure to accelerate trials, but fragmented processes, multiple vendors, and disconnected systems made execution difficult.
Critical milestones depended on external handoffs that slowed delivery, introduced rework, and limited visibility into progress. Teams lacked a consistent operating model for governing and executing key trial activities.
Improving individual processes wasn't enough. The organization needed greater operational control across the clinical trial lifecycle.
The Opportunity
The organization chose to bring critical clinical operations capabilities in-house to reduce dependency on vendors and regain control of execution.
Point B translated that strategic decision into an operating model that standardized execution across studies, improved governance, and delivered faster access to decision-grade information.
Four priorities guided the transformation:
- Regain control of critical milestones
- Standardize execution across the trial lifecycle
- Automate routine work while reducing risk
Establish governance for continuous improvement

Our Approach
Point B partnered with leaders to evaluate where time, effort, and confidence were being lost across the clinical trial lifecycle. With that in mind, the engagement focused on six core capabilities:
Build internal capability to scale
Established key clinical operations functions, from feasibility through submission, while aligning governance, roles, and accountability to support scalable execution.
Reclaim control of critical milestones
Redesigned critical workflows for database lock, blinding, and cross-functional decision-making with clear governance, operational controls, and GxP-aligned execution.
Standardize execution across the trial lifecycle
Consolidated >250 fragmented processes into standardized workflows spanning protocol development, site startup, local lab data management, database lock, and study closeout.
Automate routine work
Implemented programmable protocol deviation management and automated workflow triggers to reduce manual effort while maintaining human oversight for exceptions and critical decisions.
Drive adoption
Delivered role-based guidance and embedded ways of working that helped clinical, data management, and study teams consistently execute across studies and geographies.
Sustain improvement
Embedded governance, prioritization, and standard work to continuously improve clinical operations while supporting active studies and evolving regulatory requirements.
Outcomes
The transformation increased operational control while improving speed, consistency, and scalability across active global studies.
Operational Impact
- Database lock reduced from multi-day vendor cycles to same-day execution
- 250+ processes simplified into 60 standardized workflows
- 60+ stakeholders aligned under one operating model
Business Impact
- Faster access to top-line study results, enabling more timely portfolio decisions.
- Improved inspection readiness and reduced execution risk
- Reduced dependency on external vendors
- Greater confidence in planning and execution
- Scalable operating model that can be replicated across future studies
Key Takeaway
At its core, this wasn't a process improvement initiative. It was a strategic shift that gave the organization control over how clinical trials are executed.
By combining governance, standardized execution, and automation, Point B helped create a clinical operations model that accelerates delivery while building capability for the future. Operational excellence became a competitive advantage, not just an efficiency initiative.
RELATED INDUSTRIES


